| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kinnate Biopharma Inc. | Director | Stock Option (right to buy) | 0 | 03 Apr 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KNTE | Kinnate Biopharma Inc. | 03 Apr 2024 | 2 | $0 | 4 | Director | 05 Apr 2024, 16:55 |
| KNTE | Kinnate Biopharma Inc. | 13 Jun 2022 | 1 | $0 | 4 | Director | 15 Jun 2022, 17:00 |
| THRX | Theseus Pharmaceuticals, Inc. | 06 Oct 2021 | 0 | $0 | 3 | Director | 06 Oct 2021, 19:00 |